These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10743286)

  • 1. Vaccine adverse events in the new millennium: is there reason for concern?
    Ward BJ
    Bull World Health Organ; 2000; 78(2):205-15. PubMed ID: 10743286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
    ;
    Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety monitoring in vaccine development and immunization.
    Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
    Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a national system for dealing with adverse events following immunization.
    Mehta U; Milstien JB; Duclos P; Folb PI
    Bull World Health Organ; 2000; 78(2):170-7. PubMed ID: 10743281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concern, but not with surveillance.
    Ivinson AJ
    Bull World Health Organ; 2000; 78(2):222-3. PubMed ID: 10743292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine adverse events in the new millennium: is the sky really falling?
    Hinman AR
    Bull World Health Organ; 2000; 78(2):221-2. PubMed ID: 10743291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for reporting adverse events associated with vaccine products. Division of Immunization, Bureau of Infectious Diseases, Laboratory Center for Disease Control.
    Can Commun Dis Rep; 2000 Feb; 26 Suppl 1():I-IV, 1-18. PubMed ID: 11055081
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving global monitoring of vaccine safety: a quantitative analysis of adverse event reports in the WHO Adverse Reactions Database.
    Letourneau M; Wells G; Walop W; Duclos P
    Vaccine; 2008 Feb; 26(9):1185-94. PubMed ID: 18243428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring and assessing vaccine safety: a European perspective.
    Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
    Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions.
    Siegrist CA; Lewis EM; Eskola J; Evans SJ; Black SB
    Pediatr Infect Dis J; 2007 Nov; 26(11):979-84. PubMed ID: 17984802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse events after vaccination].
    Nøkleby H; Bergsaker MA
    Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2541-4. PubMed ID: 17028637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination vaccines: postlicensure safety evaluation.
    Chen RT; Pool V; Takahashi H; Weniger BG; Patel B
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S327-33. PubMed ID: 11709768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New viral vaccines.
    Arvin AM; Greenberg HB
    Virology; 2006 Jan; 344(1):240-9. PubMed ID: 16364754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine adverse events: separating myth from reality.
    Kimmel SR
    Am Fam Physician; 2002 Dec; 66(11):2113-20. PubMed ID: 12484693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.